CardioComm Solutions (TSXV:EKG) Total Liabilities: C$0.84 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is CardioComm Solutions Total Liabilities?

CardioComm Solutions TSXV:EKG Total Liabilities is C$0.84 Mil as of Dec. 2025. The stock has 9 warning signs investors should review.

CardioComm Solutions's Total Liabilities for the quarter that ended in Dec. 2025 was C$0.84 Mil.

CardioComm Solutions's quarterly Total Liabilities increased from Jun. 2025 (C$0.64 Mil) to Sep. 2025 (C$0.82 Mil) and increased from Sep. 2025 (C$0.82 Mil) to Dec. 2025 (C$0.84 Mil).

CardioComm Solutions's annual Total Liabilities declined from Dec. 2023 (C$0.85 Mil) to Dec. 2024 (C$0.50 Mil) but then increased from Dec. 2024 (C$0.50 Mil) to Dec. 2025 (C$0.84 Mil).


CardioComm Solutions Total Liabilities Historical Data

* Premium members only.

The historical data trend for CardioComm Solutions's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CardioComm Solutions Total Liabilities Chart

CardioComm Solutions Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.91 0.69 0.85 0.50 0.84

CardioComm Solutions Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.50 0.54 0.64 0.82 0.84

CardioComm Solutions Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

CardioComm Solutions's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=0.155--0.689
=0.84

CardioComm Solutions's Total Liabilities for the quarter that ended in Dec. 2025 is calculated as

Total Liabilities=Total Assets (Q: Dec. 2025 )-Total Equity (Q: Dec. 2025 )
=0.155--0.689
=0.84

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of C$0.84 Mil mean?
CardioComm Solutions (TSXV:EKG) has a Total Liabilities of C$0.84 Mil as of Dec. 2025. The total amount of liabilities as recorded on a company's balance sheet. View historical data for CardioComm Solutions and its competitors.
Is CardioComm Solutions' Total Liabilities too high?
CardioComm Solutions' current Total Liabilities is C$0.84 Mil.
How does CardioComm Solutions' Total Liabilities compare to VEEV and BTSG?
CardioComm Solutions' Total Liabilities of C$0.84 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Healthcare Providers & Services company?
A good Total Liabilities depends on the Healthcare Providers & Services industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for CardioComm Solutions and its competitors. CardioComm Solutions's current Total Liabilities is C$0.84 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CardioComm Solutions stock overvalued right now?
CardioComm Solutions (TSXV:EKG) has a current Total Liabilities of C$0.84 Mil. The current Total Liabilities is C$0.84 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For CardioComm Solutions (TSXV:EKG), the current Total Liabilities is C$0.84 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

CardioComm Solutions Business Description

Other Exchanges EKGGF:USA
Address 110 Sheppard Avenue East, Suite 700, North York, ON, CAN, M2N 6Y8
CardioComm Solutions Inc develops software, hardware and core laboratory reading services related to electrocardiogram (ECG) and ambulatory arrhythmia monitoring systems for medical and consumer markets globally. The Company has one operating segment, which involves the development of software and the sale of ECG recording equipment and ECG reading services for the cardiology field. Substantially all the Company's operations, assets, and employees are in Canada. Revenue is earned in Canada and the United States. Its products are GEMS Sirona, GEMS WIN, Trident Pro 40L, HeartCheck CardiBeat - Mobile ECG Device, HeartCheck SMART Monitoring, and Others.